\newcommand{\myspace}{\hspace{0.5em}}
\newgeometry{left=1.4cm, right=1.4cm, top=2.2cm, bottom=2.2cm}
\begin{landscape}
    \begin{table}[!ht]
        \centering
        \footnotesize
        \caption{Summary of model discrimination and risk of bias assessments, ordered by outcome and year published. Each row corresponds to a individual model that was either developed or externally validated in the referenced study. Unless otherwise stated, the reported c-statistics represent performance of the model risk score and not the full model equation. -: not reported; dev: development; eval: evaluation; n/a, not applicable (external validations only); perf:  performance; val: validation; \textbf{Risk of bias (RoB)}: A: analysis, O: outcome; OA: overall assessment; P: participants; Pr: predictors; +: high RoB; --: low RoB; ?: unclear RoB}
        \label{tab:sr-model-performance}
        \begin{threeparttable}
            \begin{tabularx}{\linewidth}{@{}llXXXll@{\myspace}l@{\myspace}l@{\myspace}l@{\hspace{1.1em}}l@{}}
                \toprule
                \textbf{Study}                                                                               & \textbf{Model described} & \multicolumn{3}{c}{\textbf{Model discrimination (c-statistic)}\tnote{1}} & \multicolumn{6}{c@{}}{\textbf{Risk of bias}\tnote{2}}                                                               \\
                \cmidrule(lr){3-5} \cmidrule(lr){6-11}
                ~                                                                                            & ~                        & Apparent perf.                                                           & Internal val.                                         & External val.     & Eval type       & P  & Pr & O  & A & OA \\ \midrule
                \rowcolor{rowyellow}\multicolumn{11}{@{}l@{}}{\textbf{Outcome: Registry-reported mortality}}                                                                                                                                                                                                                             \\ \midrule
                \textbf{de Araújo 2012}\cite{dearaujoEarlyClinicalManifestations2012}                        & -                        & 0.756                                                                    & -                                                     & -                 & dev             & +  & +  & ?  & + & +  \\
                \rowcolor{rowgrey}\textbf{Coura-Vital 2014}\cite{coura-vitalPrognosticFactorsScoring2014}    & -                        & 0.80 (0.78--0.82)                                                        & 0.78 (0.75--0.82)\tnote{3}                            & -                 & dev             & +  & +  & ?  & + & +  \\ \midrule
                \rowcolor{rowyellow}\multicolumn{11}{@{}l@{}}{\textbf{Outcome: In-hospital mortality}}                                                                                                                                                                                                                                   \\ \midrule
                \textbf{Werneck 2003}\cite{werneckPrognosticFactorsDeath2003}                                & -                        & 0.882                                                                    & -                                                     & -                 & dev             & +  & +  & -- & + & +  \\
                \rowcolor{rowgrey}\textbf{Sampaio 2010}\cite{sampaioRiskFactorsDeath2010}                    & -                        & 0.895                                                                    & -                                                     & -                 & dev             & +  & +  & -- & + & +  \\
                \textbf{Costa 2016}\cite{costaPredictingDeathKalaazar2016}                                   & < 2 y, clin only         & 0.90 (0.84--0.97)                                                        & -                                                     & 0.83 (0.64--1)    & dev             & -- & -- & -- & + & +  \\
                ~                                                                                            & ~                        & ~                                                                        & ~                                                     & 0.86 (0.74--0.98) & val ($\times$2) & -- & -- & -- & + & ~  \\
                \rowcolor{rowgrey}                                                                           & < 2 y, clin + lab        & 0.93 (0.88--0.98)                                                        & -                                                     & 0.80 (0.57--1)    & dev             & -- & -- & -- & + & +  \\
                \rowcolor{rowgrey}                                                                           & ~                        & ~                                                                        & ~                                                     & 0.92 (0.84--1)    & val ($\times$2) & -- & -- & -- & + & ~  \\
                ~                                                                                            & $\geq$ 2 y, clin only    & 0.89 (0.84--0.93)                                                        & -                                                     & 0.75 (0.68--0.83) & dev             & -- & -- & -- & + & +  \\
                ~                                                                                            & ~                        & ~                                                                        & ~                                                     & 0.88 (0.83--0.93) & val ($\times$2) & -- & -- & -- & + & ~  \\
                \rowcolor{rowgrey}                                                                           & $\geq$ 2 y, clin + lab   & 0.92 (0.88--0.96)                                                        & -                                                     & 0.79 (0.62--0.96) & dev             & -- & -- & -- & + & +  \\
                \rowcolor{rowgrey}                                                                           & ~                        & ~                                                                        & ~                                                     & 0.71 (0.34--1)    & val ($\times$2) & -- & -- & -- & + & ~  \\
                ~                                                                                            & Werneck 2003             & n/a                                                                      & n/a                                                   & 0.75              & val ($\times$1) & ?  & -- & -- & + & +  \\
                \rowcolor{rowgrey}                                                                           & Sampaio 2010             & n/a                                                                      & n/a                                                   & 0.87              & val ($\times$1) & ?  & -- & -- & + & +  \\
                ~                                                                                            & Coura-Vital 2014         & n/a                                                                      & n/a                                                   & 0.77              & val ($\times$1) & ?  & -- & -- & + & +  \\
                \rowcolor{rowgrey}\textbf{Abongomera 2017}\cite{abongomeraDevelopmentExternalValidation2017} & -                        & 0.83 (0.79--0.87)                                                        & 0.82 (0.77--0.88)\tnote{4}                            & 0.78 (0.72--0.83) & dev             & +  & -- & -- & + & +  \\
                \rowcolor{rowgrey}                                                                           & ~                        & ~                                                                        & ~                                                     & ~                 & val ($\times$1) & +  & -- & -- & + & ~  \\
                \textbf{Kämink 2017}\cite{kaminkClinicalSeverityScoring2017}                                 & < 19 y                   & 0.83 (0.78--0.87)                                                        & -                                                     & 0.72; 0.83; 0.77  & dev             & +  & +  & -- & + & +  \\
                ~                                                                                            & ~                        & ~                                                                        & ~                                                     & ~                 & val ($\times$3) & +  & +  & ?  & + & ~  \\
                \rowcolor{rowgrey}                                                                           & $\geq$ 19 y              & 0.74 (0.68--0.81)                                                        & -                                                     & 0.72; 0.80; 0.71  & dev             & +  & +  & -- & + & +  \\
                \rowcolor{rowgrey}                                                                           & ~                        & ~                                                                        & ~                                                     & ~                 & val ($\times$3) & +  & +  & ?  & + & ~  \\
                \textbf{Foinquinos 2021}\cite{foinquinosTemporalValidationPredictive2021}                    & Sampaio updating         & 0.556                                                                    & -                                                     & -                 & dev             & +  & +  & -- & + & +  \\
                ~                                                                                            & ~                        & 0.762 (0.662--0.901)\tnote{5}                                            & ~                                                     & ~                 & ~               &    &    &    &   & ~  \\
                \rowcolor{rowgrey}                                                                           & Sampaio 2010             & n/a                                                                      & n/a                                                   & 0.618\tnote{5}    & val ($\times$1) & +  & +  & -- & + & +  \\ \bottomrule
            \end{tabularx}
            \begin{tablenotes}
                \footnotesize
                \item[1] Significant figures and 95\% confidence intervals are reproduced as reported in the publication.
                \item[2] For studies presenting multiple external validations of the same model, risk of bias assessments were the same and therefore grouped together.
                \item[3] Split-sample (random split with 2:1 development:validation).
                \item[4] Cross-validation (5-fold).
                \item[5] C-statistic from evaluation of full model equation.
            \end{tablenotes}
        \end{threeparttable}
    \end{table}
\end{landscape}
\restoregeometry